
Breast Cancer Survival Rates Exceed 85% Among Israeli Women
New Health Ministry data reveals breast cancer survival rates for Israeli women exceed 85% despite high incidence, with 5,565 new cases diagnosed in 2023.

New Health Ministry data reveals breast cancer survival rates for Israeli women exceed 85% despite high incidence, with 5,565 new cases diagnosed in 2023.
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".

Israeli scientists identify early DNA "weak spots" that may detect breast cancer years before it starts. This Hebrew University study offers new hope for.

Israeli scientists from Tel Aviv University made a breakthrough, discovering how breast cancer adapts to the brain, paving the way for new treatments for 10-15%.